Trio-Tech director sells 22,000 shares
TRIO-TECH INTERNATIONAL director Jason T. Adelman reported a series of open-market stock sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TRIO-TECH INTERNATIONAL director Jason T. Adelman reported a series of open-market stock sales. Between March 5 and March 16, 2026, he sold a total of 22,000 shares of common stock in four transactions at prices between $5.53 and $5.82 per share. After these sales, he directly holds 50,000 shares of Trio-Tech common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $5.6066 | $28K |
| Sale | Common Stock | 5,000 | $5.8164 | $29K |
| Sale | Common Stock | 7,489 | $5.5322 | $41K |
| Sale | Common Stock | 4,511 | $5.5475 | $25K |
Key Figures
Key Terms
open-market sale financial
non-derivative financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Trio-Tech International (TRT) report in this Form 4?
Were any derivatives or options involved in Jason T. Adelman’s Trio-Tech (TRT) transactions?
Were Jason T. Adelman’s Trio-Tech (TRT) sales classified as open-market transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.